Cargando…

Antibody targeted CpG for the immunotherapy of solid tumors

Detalles Bibliográficos
Autores principales:	Epstein, Alan L, Jang, Julie, Hu, Peisheng, Khawli, Leslie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649365/ http://dx.doi.org/10.1186/2051-1426-3-S2-P287

Ejemplares similares

Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5- fluorouracil chemotherapy in the B16 melanoma model
por: Rakhmilevich, Alexander, et al.
Publicado: (2013)

Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations
por: Boune, Souad, et al.
Publicado: (2020)

CpG methylation as a tool to characterize cell-free Epstein-Barr virus DNA
por: Shamay, Meir, et al.
Publicado: (2012)

CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen, Wenqiang, et al.
Publicado: (2021)

CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function
por: Jang, Hyun Sik, et al.
Publicado: (2017)

The revival of CpG oligonucleotide-based cancer immunotherapies
por: Adamus, Tomasz, et al.
Publicado: (2018)

Screening genome-wide DNA methylation CpG sites via training and testing data utilizing surrogate variables
por: Ray, Meredith, et al.
Publicado: (2014)

Methylation and hydroxymethylation of CpG display dynamic landscapes in early embryo development and define differentiation into embryonic and placental lineages
por: Li, Yan, et al.
Publicado: (2013)

Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives
por: Kouhi, Aida, et al.
Publicado: (2021)

Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)

CpG methylation controls reactivation of HIV from latency
por: Blazkova, Jana, et al.
Publicado: (2010)

Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005)

Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread
por: van den Hout, Mari F, et al.
Publicado: (2013)

Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015)

In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases
por: Arand, Julia, et al.
Publicado: (2012)

Prediction of CpG-island function: CpG clustering vs. sliding-window methods
por: Hackenberg, Michael, et al.
Publicado: (2010)

CpG Methylation Altered the Stability and Structure of the i-Motifs Located in the CpG Islands
por: Oshikawa, Daiki, et al.
Publicado: (2022)

The Effects of O(6)-methyl Guanine DNA-methyl Transferase Promotor Methylation and CpG1, CpG2, CpG3 and CpG4 Methylation on Treatment Response and their Prognostic Significance in Patients with Glioblastoma
por: Yildiz, OG, et al.
Publicado: (2020)

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
por: Ursu, Renata, et al.
Publicado: (2015)

The Control Region of Mitochondrial DNA Shows an Unusual CpG and Non-CpG Methylation Pattern
por: Bellizzi, Dina, et al.
Publicado: (2013)

Evaluation of single CpG sites as proxies of CpG island methylation states at the genome scale
por: Barrera, Víctor, et al.
Publicado: (2012)

Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
por: Goldsmith, Chloe, et al.
Publicado: (2021)

Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy
por: Lin, Adam Yuh, et al.
Publicado: (2013)

Sustained release of tumor cell lysate and CpG from an injectable, cytotoxic hydrogel for melanoma immunotherapy
por: Yang, Kui, et al.
Publicado: (2023)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

CpGIF: an algorithm for the identification of CpG islands
por: Sujuan, Ye, et al.
Publicado: (2008)

Bidding the CpG island goodbye
por: Greally, John M
Publicado: (2013)

CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015)

CpG islands or CpG clusters: how to identify functional GC-rich regions in a genome?
por: Han, Leng, et al.
Publicado: (2009)

In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size
por: Shyamala, Nivas, et al.
Publicado: (2022)

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

Nanoparticulate CpG Immunotherapy in RAO‐Affected Horses: Phase I and IIa Study
por: Klier, J., et al.
Publicado: (2015)

Regulating the surface topography of CpG nanoadjuvants via coordination-driven self-assembly for enhanced tumor immunotherapy
por: Zhang, Li, et al.
Publicado: (2023)

B7-h3-specific engager T cells for the immunotherapy of pediatric solid tumors
por: DeRenzo, Christopher, et al.
Publicado: (2015)

CpGPAP: CpG island predictor analysis platform
por: Chuang, Li-Yeh, et al.
Publicado: (2012)

Retrotransposition creates sloping shores: a graded influence of hypomethylated CpG islands on flanking CpG sites
por: Grandi, Fiorella C., et al.
Publicado: (2015)

Production of antibodies with peptide-CpG-DNA-liposome complex without carriers
por: Kim, Dongbum, et al.
Publicado: (2011)

CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody
por: Hiramatsu, Kosuke, et al.
Publicado: (2015)

Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors
por: Triozzi, Pierre, et al.
Publicado: (2015)

Human hybridoma and recombinant Pritumumab antibodies for treatment of human solid tumors
por: Gupta, Rishab, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ut7u2puui2vllbm4ritet2n64i